Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We compared the effect of haematopoietic growth factors
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
), interleukin (IL)-1, IL-3, and IL-5 on the functional activation of human eosinophils and neutrophils from the same donor. All four colony-stimulating factors (CSF) enhanced the phagocytosis of Candida albicans by eosinophils and increased staphylococcal, but not Candida, killing.
GM-CSF
and IL-5 had a profound stimulating effect on eosinophil staphylocidal activity.
GM-CSF
and IL-3 enhanced the generation of leukotriene C4 (LTC4) induced by calcium ionophore A23187 and the release of
arylsulphatase
and beta-glucuronidase from specific and small granules of eosinophils. In contrast, IL-1 and IL-5 had no effect on degranulation.
GM-CSF
and IL-1 enhanced phagocytosis of C. albicans by neutrophils, and
GM-CSF
stimulated degranulation and the release of the enzymes beta-glucuronidase and
arylsulphatase
from neutrophils while IL-1 stimulated the release of
arylsulphatase
only. This study indicates that the eosinophil-active colony-stimulating factors can markedly enhance the host defence function of the eosinophil and even make it the equal of the neutrophil in staphylocidal activity. The CSF-activated eosinophil, however, may cause inappropriate inflammation and normal tissue damage.
...
PMID:Activation of human eosinophil and neutrophil functions by haematopoietic growth factors: comparisons of IL-1, IL-3, IL-5 and GM-CSF. 155 Jul 68
We have previously shown that normal-density human peripheral blood eosinophils transcribe and translate mRNA for
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
) and that the intracellular distribution was granular as assessed by light microscopy immunocytochemistry. The present study was conducted to confirm this apparent association between
GM-CSF
and the crystalloid granule using a subcellular fractionation method for human eosinophils and immunogold electron microscopy (EM). Highly purified (> 99%, by negative selection using anti-CD16 immunomagnetic microbeads) human peripheral blood eosinophils were obtained from four asthmatic subjects (not taking systemic medication), homogenized and density fractionated (5 x 10(7) cells/subject) on linear Nycodenz gradients. Twenty-four fractions were collected from each cell preparation and analyzed for marker enzyme activities as well as total protein. Dot blot analysis with specific monoclonal antibodies (MoAbs) was used to detect the eosinophil granule proteins major basic protein (MBP) and eosinophil cationic protein (ECP). An anti-CD9 MoAb was used as an eosinophil plasma membrane marker. Lactate dehydrogenase (LDH) was used as a cytosolic marker. Immunoreactivity for
GM-CSF
was detected by a specific enzyme-linked immunosorbent assay using a polyclonal antihuman
GM-CSF
antibody and confirmed by dot blot.
GM-CSF
coeluted with the cellular fractions containing granule markers (MBP, ECP, eosinophil peroxidase, hexosaminidase, and
arylsulphatase
), but not those containing cytoplasm (LDH+) or membrane (CD9+) markers. EM examination of pooled fractions associated with the peak of
GM-CSF
immunoreactivity confirmed that they contained crystalloid and small granules, but not plasma membrane. In addition, quantification, using immunogold labeling with an anti/
GM-CSF
MoAb, indicated preferential localization of gold particles over the eosinophil granule cores of intact cells. Thus, our results indicate that
GM-CSF
resides as a granule-associated, stored mediator in unstimulated human eosinophils.
...
PMID:Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. 772 86
The potentiating effects of a variety of recombinant cytokines on the survival or proliferation (or both) of sheep bone marrow eosinophils in vitro were assessed by means of cell-specific enzyme microassays for eosinophil peroxidase (EPO) and eosinophil
arylsulphatase
(EAS). In this system recombinant human and mouse interleukin 5 (rhIL5 and rmIL5, respectively) had potent eosinophil potentiating activity (EPA) that was reciprocally inhibited by polyclonal anti-rhIL5 and anti-rmIL5 antibodies and by a specific monoclonal anti-rmIL5 (TRFK5). Recombinant ovine
granulocyte-macrophage colony-stimulating factor
(rovGM-CSF) and interleukin 3 (rovIL3) also had marked EPA for sheep cells, and the activity of the former was blocked by a mouse monoclonal anti-rovGM-CSF. The equivalent human and murine recombinant GM-CSFs and IL3s had no detectable effect on sheep eosinophils, nor did antibodies against them influence the EPA of any of the ovine cytokines. The evidence presented provides further support to the concept that the structure, biological reactivity and cell specificity of IL5 is highly conserved in mammals, whereas other eosinopoietins such as IL3 and GM-CSF are more species-specific.
...
PMID:Cross-reactivity amongst recombinant haematopoietic cytokines from different species for sheep bone-marrow eosinophils. 796 31